The 'power' of signal-detection algorithms

Comment

M Rezaul Karim et al. Drug Saf. 2008.

. 2008;31(3):271-2, author reply 272-3.

doi: 10.2165/00002018-200831030-00008.

No abstract available

Comment on

Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.
Matsushita Y, Kuroda Y, Niwa S, Sonehara S, Hamada C, Yoshimura I. Matsushita Y, et al. Drug Saf. 2007;30(8):715-26. doi: 10.2165/00002018-200730080-00008. Drug Saf. 2007. PMID: 17696584

Safety surveillance of longitudinal databases: further methodological considerations.
Schuemie MJ. Schuemie MJ. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):670-2; author reply 673-5. doi: 10.1002/pds.3259. Pharmacoepidemiol Drug Saf. 2012. PMID: 22678687 No abstract available.
Safety surveillance of longitudinal databases: methodological considerations.
Norén GN, Hopstadius J, Bate A, Edwards IR. Norén GN, et al. Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):714-7. doi: 10.1002/pds.2151. Epub 2011 Jun 2. Pharmacoepidemiol Drug Saf. 2011. PMID: 21638520 No abstract available.
What Is the Plural of a 'Yellow' Anecdote?
Evans SJ. Evans SJ. Drug Saf. 2016 Jan;39(1):1-3. doi: 10.1007/s40264-015-0368-7. Drug Saf. 2016. PMID: 26597283 No abstract available.
Methods for safety signal detection in healthcare databases: a literature review.
Arnaud M, Bégaud B, Thurin N, Moore N, Pariente A, Salvo F. Arnaud M, et al. Expert Opin Drug Saf. 2017 Jun;16(6):721-732. doi: 10.1080/14740338.2017.1325463. Epub 2017 May 15. Expert Opin Drug Saf. 2017. PMID: 28490262 Review.
Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.
Lai EC, Pratt N, Hsieh CY, Lin SJ, Pottegård A, Roughead EE, Kao Yang YH, Hallas J. Lai EC, et al. Eur J Epidemiol. 2017 Jul;32(7):567-582. doi: 10.1007/s10654-017-0281-8. Epub 2017 Jul 11. Eur J Epidemiol. 2017. PMID: 28698923 Review.